
Enrollment of the first patient for T-1301 Phase I clinical trial was achieved in August, 2022.
T-1301 Phase I clinical trial was initiated in Mid-December, 2021 in multiple centers in Taiwan. Getting through the tough 2022Q2 due to COVID-19 affected patient